Literature DB >> 2948444

In vitro activity of imipenem against enterococci and staphylococci and evidence for high rates of synergism with teicoplanin, fosfomycin, and rifampin.

E Debbia, P E Varaldo, G C Schito.   

Abstract

The in vitro activities of imipenem alone and in combination with teicoplanin, fosfomycin, and rifampin were tested against clinical isolates of enterococci and staphylococci. In both groups of organisms, the three combinations demonstrated high rates of synergism in both checkerboard and time-kill studies.

Entities:  

Mesh：

Substances：

Year:  1986        PMID： 2948444      PMCID： PMC176544          DOI： 10.1128/AAC.30.5.813

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN： 0066-4804            Impact factor:   5.191


  20 in total

1.  Synergistic effect of N-formimidoyl thienamycin with gentamicin and amikacin against Streptococcus faecalis.

Authors:  M E Gombert; L B Berkowitz; M C Cummings
Journal:  Antimicrob Agents Chemother       Date:  1983-02       Impact factor: 5.191

2.  Synergism between N-formimidoyl thienamycin and gentamicin or tobramycin against enterococci.

Authors:  C Watanakunakorn; J C Tisone
Journal:  Antimicrob Agents Chemother       Date:  1982-12       Impact factor: 5.191

3.  Simplified lyogroup system, a new method for routine identification of staphylococci: description and comparison with three other methods.

Authors:  P E Varaldo; G Grazi; O Soro; G Cisani; G Satta
Journal:  J Clin Microbiol       Date:  1980-07       Impact factor: 5.948

4.  Lack of in vivo and in vitro bactericidal activity of N-formimidoyl thienamycin against enterococci.

Authors:  R Auckenthaler; W R Wilson; A J Wright; J A Washington; D T Durack; J E Geraci
Journal:  Antimicrob Agents Chemother       Date:  1982-09       Impact factor: 5.191

5.  Comparative in vitro activity of N-formimidoyl thienamycin against gram-positive and gram-negative aerobic and anaerobic species and its beta-lactamase stability.

Authors:  H C Neu; P Labthavikul
Journal:  Antimicrob Agents Chemother       Date:  1982-01       Impact factor: 5.191

6.  In vitro activities of rifapentine and rifampin, alone and in combination with six other antibiotics, against methicillin-susceptible and methicillin-resistant staphylococci of different species.

Authors:  P E Varaldo; E Debbia; G C Schito
Journal:  Antimicrob Agents Chemother       Date:  1985-04       Impact factor: 5.191

7.  In vitro activity of teichomycin and vancomycin alone and in combination with rifampin.

Authors:  P E Varaldo; E Debbia; G C Schito
Journal:  Antimicrob Agents Chemother       Date:  1983-03       Impact factor: 5.191

8.  In vitro evaluation of N-formimidoyl thienamycin (MK0787) combined with amikacin against gram-negative bacilli and Staphylococcus aureus.

Authors:  M Díez Enciso; M Mateos Lindemann; A Gutiérrez Altés
Journal:  Antimicrob Agents Chemother       Date:  1982-12       Impact factor: 5.191

9.  In-vitro antagonism by N-formimidoyl thienamycin and cefoxitin of second and third generation cephalosporins in Aeromonas hydrophila and Serratia marcescens.

Authors:  M A Miller; M Finan; M Yousuf
Journal:  J Antimicrob Chemother       Date:  1983-04       Impact factor: 5.790

10.  Current problems in the treatment of infective endocarditis due to Pseudomonas aeruginosa.

Authors:  M P Reyes; A M Lerner
Journal:  Rev Infect Dis       Date:  1983 Mar-Apr
View more
  10 in total

1.  Characterization of passage-selected vancomycin-resistant Staphylococcus aureus strains of diverse parental backgrounds.

Authors:  R F Pfeltz; V K Singh; J L Schmidt; M A Batten; C S Baranyk; M J Nadakavukaren; R K Jayaswal; B J Wilkinson
Journal:  Antimicrob Agents Chemother       Date:  2000-02       Impact factor: 5.191

2.  Failure of routine susceptibility tests to detect imipenem resistance among strains of methicillin-resistant Staphylococcus aureus.

Authors:  J M Boyce; E Papa; R Dickenson; A A Medeiros
Journal:  Antimicrob Agents Chemother       Date:  1991-07       Impact factor: 5.191

Review 3.  Fosfomycin: an old, new friend?

Authors:  M Popovic; D Steinort; S Pillai; C Joukhadar
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2009-11-14       Impact factor: 3.267

4.  In vitro activity of LY146032 alone and in combination with other antibiotics against gram-positive bacteria.

Authors:  E Debbia; A Pesce; G C Schito
Journal:  Antimicrob Agents Chemother       Date:  1988-02       Impact factor: 5.191

5.  Comparative antibacterial activity of L-695,256, a carbapenem active against methicillin-resistant staphylococci.

Authors:  M Rylander; J Rollof; K Jacobsson; S R Norrby
Journal:  Antimicrob Agents Chemother       Date:  1995-05       Impact factor: 5.191

6.  Synergy of fosfomycin with other antibiotics for Gram-positive and Gram-negative bacteria.

Authors:  Antonia C Kastoris; Petros I Rafailidis; Evridiki K Vouloumanou; Ioannis D Gkegkes; Matthew E Falagas
Journal:  Eur J Clin Pharmacol       Date:  2010-02-26       Impact factor: 2.953

7.  Dactimicin, a new aminoglycoside: in vitro activity, post-antibiotic effect and interaction with other antibiotics.

Authors:  P Paglia; G Molinari; A Pesce; E A Debbia
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1989-07       Impact factor: 3.267

8.  In vitro synergistic effects of double and triple combinations of beta-lactams, vancomycin, and netilmicin against methicillin-resistant Staphylococcus aureus strains.

Authors:  S Rochon-Edouard; M Pestel-Caron; J F Lemeland; F Caron
Journal:  Antimicrob Agents Chemother       Date:  2000-11       Impact factor: 5.191

9.  In vitro interactions between different beta-lactam antibiotics and fosfomycin against bloodstream isolates of enterococci.

Authors:  M Pestel; E Martin; C Aucouturier; J F Lemeland; F Caron
Journal:  Antimicrob Agents Chemother       Date:  1995-10       Impact factor: 5.191

10.  Interactions between glycopeptides and beta-lactams against isogenic pairs of teicoplanin-susceptible and -resistant strains of Staphylococcus haemolyticus.

Authors:  Carla Vignaroli; Francesca Biavasco; Pietro E Varaldo
Journal:  Antimicrob Agents Chemother       Date:  2006-07       Impact factor: 5.191
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.